Goldman Sachs
IRD

Goldman Sachs’s Opus Genetics IRD Stock Holding History

Goldman Sachs’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.49M Buy
+326,809
New +$1.13M ﹤0.01% 4789
2021
Q3 		– Sell
-37,315
Closed -$197K – 6566
2021
Q2 		$197K Buy
+37,315
New +$185K ﹤0.01% 5748
2017
Q2 		– Sell
-84
Closed -$21K – 7017
2017
Q1 		$21K Hold
84
– – ﹤0.01% 6503
2016
Q4 		$6K Hold
84
– – ﹤0.01% 6809
2016
Q3 		$9K Sell
84
-17
-17% -$2.05K ﹤0.01% 6886
2016
Q2 		$12K Hold
101
– – ﹤0.01% 6833
2016
Q1 		$16K Buy
101
+17
+20% +$2.83K ﹤0.01% 6802
2015
Q4 		$15K Hold
84
– – ﹤0.01% 6906
2015
Q3 		$21K Sell
84
-40
-32% -$10.9K ﹤0.01% 7023
2015
Q2 		$36K Hold
124
– – ﹤0.01% 6957
2015
Q1 		$44K Sell
124
-130
-51% -$47.2K ﹤0.01% 6731
2014
Q4 		$85K Sell
254
-75
-23% -$25.9K ﹤0.01% 6638
2014
Q3 		$128K Buy
329
+201
+157% +$72.4K ﹤0.01% 6457
2014
Q2 		$53K Sell
128
-61
-32% -$27.7K ﹤0.01% 6746
2014
Q1 		$98K Buy
189
+105
+125% +$56.8K ﹤0.01% 6402
2013
Q4 		$21K Hold
84
– – ﹤0.01% 6535
2013
Q3 		$19K Hold
84
– – ﹤0.01% 6433
2013
Q2 		$18K Buy
+84
New +$14.4K ﹤0.01% 6200

Other funds holding IRD

CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Goldman Sachs's IRD Position: Q1 2026 in Review

Goldman Sachs opened a new position in Opus Genetics (IRD) in Q1 2026: 326,809 shares worth $1.49M. The stake represents ﹤0.01% of the portfolio and ranks #4789 among its holdings. This is a return to the name: Goldman Sachs previously reported a position in IRD as recently as Q2 2021.

Goldman Sachs first reported a position in IRD in Q2 2013 and has held it in 18 quarters since. 79 funds tracked by Wall St. Rank hold IRD as of Q1 2026.

  • Goldman Sachs held 326,809 shares of Opus Genetics worth $1.49M as of Q1 2026.
  • Opus Genetics was a new Goldman Sachs position in Q1 2026.
  • Opus Genetics made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #4789 holding.
  • Goldman Sachs first reported a position in Opus Genetics in Q2 2013 and has held it in 18 quarters since.
  • 79 funds tracked by Wall St. Rank held Opus Genetics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.